Boots has launched a medical cannabis service offering eligible patients prescriptions delivered discreetly to their doors.
The new SureLeaf service is aimed at people aged 25 and over living with certain chronic pain conditions, generalised anxiety disorder or insomnia.
However, cannabis will not be available to purchase from Boots shelves or without a prescription.
READ MORE: Costa announces major update affecting over 140 Next stores across UK
The private service operates through Boots Online Doctor and is intended for patients whose symptoms have not been adequately relieved by conventional treatments, as reported by What’s The Jam.
Eligible pain conditions include fibromyalgia, arthritis, sciatica, chronic migraines, endometriosis, back and neck pain, neuropathy and complex regional pain syndrome.
It may also support patients with cancer-related pain, multiple sclerosis, spinal injuries and palliative-care symptoms.
A free online check is available to indicate whether someone may qualify.
Patients must then submit their medical history before attending a video consultation with a doctor listed on the General Medical Council’s Specialist Register.
Any proposed prescription is independently reviewed by a clinical team, including a second consultant, before treatment begins.
The one-month introductory trial costs £89 and includes a specialist assessment, a 10ml oil starter dose and an end-of-month review.
An annual plan costs £99 and includes an initial assessment and four follow-up appointments, although medication and additional consultations are charged separately.
Cannabis flower starts at £38, while sublingual cannabis oil costs from £35.
The flower is ground and inhaled using a medically approved vaporiser, while oils are measured and taken under the tongue.
Boots warns that smoking prescribed cannabis remains illegal.
Patients who begin treatment will be reviewed after 28 days and then at least once every three months.
Dr David Gwynne, medical director at Boots Online Doctor, said: “Medical cannabis is not appropriate for everyone and prescribing decisions need to be made carefully on an individual patient basis.”
Possible side effects include drowsiness, dizziness, dry mouth, reduced concentration, mood changes and impaired coordination.
Cannabis-based medicines have been legal on prescription in the UK since 2018, but recreational cannabis remains illegal.
The NHS says very few people receive cannabis prescriptions through the health service and that evidence supporting its use for long-term pain is not currently strong enough for it to be routinely recommended.
Many cannabis-based medicines are also unlicensed, meaning they have not received standard UK marketing authorisation for the conditions in question.
Boots and the University of Nottingham are now exploring a research programme examining patient outcomes and prescribing practices for chronic pain.
The service and its available treatments can be found through Boots Online Doctor.
READ MORE: Tesco launches three indulgent hot dips perfect for ‘sleepover scran’
